TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $10.03B | $2.18B |
| FY2021 | — | $10.28B | $2.17B |
| FY2022 | — | $9.81B | $2.80B |
| FY2023 | — | $8.50B | $3.23B |
| FY2024 | — | $5.37B | $3.30B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $10.03B | $2.18B |
| FY2021 | — | $10.28B | $2.17B |
| FY2022 | — | $9.81B | $2.80B |
| FY2023 | — | $8.50B | $3.23B |
| FY2024 | — | $5.37B | $3.30B |